Institute of Health Economics and Management (IHEM Asia-Pacific)
IHEM Asia-Pacific was established to share knowledge and experiences between Europe and Asia-Pacific and to stimulate the exchange of ideas, enriched by the contribution of high level scholars and experts from the region. It offers a wide variety of executive education programs for junior and senior managers working in health organizations such as hospitals, biopharmaceutical companies and public health agencies.
About the Institute
ESSEC has been committed for more than 20 years to the needs of higher education for top healthcare executives, with the Chair of Health Systems and the Chair of Therapeutic Innovation. The Institute of Health Economics and Management, ESSEC Business School has a team of faculty members and permanent researchers and hosts the two chairs. It offers a wide variety of executive education programmes for middle and senior managers working in health organisations such as hospitals, biopharmaceutical companies and public health agencies.
The Institute is also dedicated to the creation of scientific knowledge through its research in areas such as health technology assessment, strategic hospital management, primary healthcare services funding and organisation, health insurance economics, and the impact of health regulations on biomedical innovation and market access. Researchers are regularly invited to participate on expert panels by healthcare authorities. They also offer consultancy services for private organisations on national and international issues.
Launch of IHEM Asia-Pacific
ESSEC Business School established its Asia-Pacific campus in Singapore in 2005, and has since played key roles in various academic and business areas. The healthcare sector is yet another key area.
The unprecedented economic growth throughout Asia-Pacific has enabled great gains in life expectancy. In many of the Asia-Pacific countries, this has been achieved within 40 years, whereas it took old Europe nearly over a century. However, population ageing, epidemiological transition, the prevalence of communicable diseases and a rise of chronic diseases pose a constant challenge. There is a real demand for accessible, high quality healthcare services, supported by a concurrent demand for health insurance.
With its longstanding experience in providing educational programs in the fields of Health Economics and Management, ESSEC Business School adds the expertise of providing a comprehensive insight from the continental Europe experience. The ESSEC Institute of Health Economics and Management (IHEM) Asia-Pacific was established to share knowledge and experiences between Europe and Asia-Pacific and to stimulate the exchange of ideas, enriched by the contribution of high level scholars and experts from the region.
Corporate sponsors of the Institute
The Institute benefits from educational grants from ABBVIE, EFPIA, IPSEN, JANSSEN, LUNDBECK, SANOFI, UCB, and VIFOR PHARMA. It is fully dedicated to funding the development of activities of the Institute in Asia-Pacific including the intensive HTA programs and the Health Policy Forums.
The Forum also benefited from additional grants from:
Prof. Gérard de Pouvourville, Director, ESSEC Institute of Health Economics and Management
Professor Gérard de Pouvourville is Chair Professor at ESSEC Business School for Health Systems and Director of the Institute of Health Economics and Management and is graduated from the prestigious French Ecole Polytechnique. Prof. de Pouvourville's major research areas are in health policy, healthcare financing and health technology assessment. He recently co-published a book on globalization of managerial innovations in the field of healthcare management and is also co-author of a handbook on health economics and management. Gerard is an advisor to the French Ministry of Health, to the French National Sickness Fund and consults for major pharmaceutical companies.
Mrs. Annie Chicoye, Executive Director for Development, Institute of Health Economics and Management
Mrs. Annie Chicoye served as civil servant in the French Ministry of Health, before joining a major pharmaceutical company where she initiated the Government Affairs and Health Economics Department. She funded and managed a leading consulting company internationally connected with Europe and the US. Her field of competences covers health policy, health technology assessment, pricing and reimbursement, public health programs assessment including disease management and telemedicine. She lectures at ESSEC Business School and the Institut d’Etudes Politiques de Paris.
Mr. Joe Caputo, Associate Director, Institute of Health Economics and Management Asia-Pacific
Mr. Joe Caputo’s background and experience spans industry and consulting roles across multiple continents. He spent 14 years with a major global pharmaceutical company where he worked across a number of roles including drug development, sales & marketing and UK & global health outcomes. Following a successful transition into consulting, he worked as a Principal at IMS Health, subsequently moving to Singapore in 2012 to set up and manage the Real-World Evidence and HEOR team for the Asia-Pacific region. His expertise includes RWE/HEOR strategy development, health technology assessment, use of patient level data and value communications. He is a lecturer for ESSEC Business School Asia-Pacific and is often invited to speak at international conferences. He has also attended many company meetings as an industry expert, and in 2012 was invited to present an overview of HTA to the China FDA.
ESSEC MSc in Management of Health Industries
The MSc in Management of Health Industries program is a one-year program delivered in Singapore, tailored for working professionals and graduates devoted to the business of healthcare. The program provides comprehensive insights into healthcare management, drawing from ESSEC's European experience while integrating regional healthcare management best practices.
- A truly Asian perspective on the health industries, with case studies taught by industry thought-leaders and professors from Europe and Asia
- Emphasis on developing cross-functional management skills in addition to acquiring a *technical and analytical skill set *
- A one-year program delivered in Singapore over evening sessions and Saturdays fortnightly
Annual Health Policy Decision Makers Forum
The Forum is a high-ranking international conversational platform in which key opinion leaders in policy making bodies, academics, and health industries extensively exchanged perspectives on top priority health issues encountered by Asia-Pacific countries and significant innovative solutions to tackle those pressing problems.
Following the successful First and Second Health Policy Decision Makers Forum Asia-Pacific (the Forum, in short) in Singapore and Shanghai, the third Forum was held at the newly inaugurated ESSEC Asia-Pacific campus on 5 & 6 June 2015.
The Forum attracted more than 100 participants from the region, and addressed the following topics:
- Policy models considering their spill-overs and compatibility with sustainable and affordable access to care
- Experiences and concerns from global companies investing in the Asia-Pacific region
- Diversity of solutions for the region, considering the variety of economies and healthcare systems
Find out more about what was discussed and watch the highlight video and interviews from the Forum here.
Health, Business and Society (HBS) Public Talk Series
The Health, Business and Society (HBS) Public Talk series was initiated with the aim of facilitating and disseminating insights to relevant stakeholders in the industry, so as to deliver meaningful recommendations to both public and private policy decision makers.
Six public talks were successfully held in 2014, each featuring a different topic and speakers from the public and private sectors, as well as academia. IHEM Asia-Pacific would like to thank all speakers, supporting partners and participants, for making the series a success and look forward to the continued support for the HBS Public Talk series.
Click on the following links to read more about the HBS Public Talk series held in 2014
HBS #7: Collaborative Governance in Fighting Emerging Infectious Disease
HBS Roundtable: Harnessing Innovation for Unmet Needs in Healthcare in Asia
HBS #9: 21st Century Global Harmonization of Healthcare Regulation: A USFDA Perspective
HBS #10: Aligning Financials for Healthy Behaviors: Implications to Payers, Providers and Society